|
Offered services
Full clinical development phase II – IV projects (from strategic planning and protocol writing to final study report) under GCP and GLP conditions
Individual services on:
- Study design
- Protocol writing
- Clinical analytics and central laboratory in collaboration with our partners
- CRF design
- Study conduct and monitoring according to GCP and international ICH guidelines
- Biometry
- Final study report (ICH E3)
- Scientific interpretation of results
- Investigational drug import to Europe
- Study drug packing together with our partners
- Biometry including database design, data entry, quality checks, generation of tables, graphs and statistical analysis according to ICH criteria
Special in-house knowledge of the following therapeutic areas and development research activities:
- CNS (Neurology: Alzheimer disease, general spasms, epilepsy, head trauma, stroke, migraine, multiple sclreosis, amyolateral sclerosis; Psychiatry: depression, schizophrenia, pain, bipolar disorder, aggression, social phobia)
- Cardiovascular (Indications: hypertension, congestive heart failure)
- Rheumatology (Indications: osteoid and rheumatoid arthritis)
- Anti - platelet drugs (Indications: PTCA, acute coronary syndrome, stroke)
- Respiratory (Asthma, inhalative devices)
- Oncology (Biological response modifiers, supportive therapy to chemotherapy)
- Immunology (Transplantation, allergy, atopical dermatitis)
- Anti-glaucoma drugs
- Topical formulations (Including nasal sprays, eye-drops, transdermal application systems)
- Genitourinary
- Medical devices
- Life-cycle developments (e.g. slow release, i.v. and nasal formulations)
- Gene technology products (e.g. Cytokines, vaccines)
- Additional expertise available in our specialist network
Please contact:
Rolf Pokorny, M.D., M.Sc.
Head of Clinical Research/Biometrics
Lettenweg 118
CH-4123 Allschwil , Switzerland
Tel.: +41 / 61 / 487 24 00
Fax: +41 / 61 / 487 24 01
e-mail: rpokorny@pharmacontract.ch
|
|